Linked Life Data

19339952

Source:http://linkedlifedata.com/resource/pubmed/id/19339952

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-4-2
pubmed:abstractText
Clinical trials of CCR5 antagonists attest to their efficacy and tolerance in HIV treatment. However, there has been debate on their long-term safety because of the role of CCR5 in innate immunity. This review highlights gaps in our understanding of epidemiology of infections that are modulated by CCR5, in particular, in HIV-infected individuals.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1746-6318
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
131-5
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Safety concerns about CCR5 as an antiviral target.
pubmed:affiliation
Institute of Microbiology, University Hospital Center, University of Lausanne, Lausanne, Switzerland. Amalio.Telenti@chuv.ch
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't